Harnessing IgA: A Breakthrough in HIV Vaccine Innovation
A vaccine eliciting strong IgA responses could revolutionize HIV prevention by protecting the virus’s primary entry points.
A vaccine eliciting strong IgA responses could revolutionize HIV prevention by protecting the virus’s primary entry points.
The future of prostate cancer vaccines lies in combination therapies that harness the strengths of multiple modalities.
In the fight against malaria, the genome of P. falciparum is both a roadmap and a battleground.
Hepatitis E virus (HEV), traditionally understood as a hepatotropic pathogen, is now recognized for its far-reaching consequences, extending to extrahepatic manifestations such as neurological disorders
Comparative analysis of immune responses in pediatric bronchiolitis reveals significant heterogeneity in the host response to RSV, HRV, and FLU infections.
CDC tackles fatal fungal meningitis outbreak linked to surgeries in Matamoros, Mexico.
EBV attacks fragile DNA, inducing malfunction linked to a number of malignancies.
Aminoglycosides get their name from the fact that they have structures made of amino sugars joined together glycosidically.
NIH experts offer perspective on next-generation approaches in developing mucosal vaccines for respiratory viruses.
STEMart eyes prospective market in democratizing sterilization services for medical device biological indicators.
Asthmatic, allergenic and immunologic triggers hosted by most used gadget of the 21st century – smartphones.
Scientists elucidate mosquito’s preferential snacking of human blood over others with skin odorants as bases for experimentation.
People with HIV have an internal body clock that is greatly delayed, consistent with the symptoms of jet lag.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings